What is TrivarX Limited (MDBIF)?

TrivarX Limited (MDBIF) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

What is the current price of MDBIF?

The current price of MDBIF is $0.01. Prices are updated in real time on Stocks360.

What is MDBIF's price-to-earnings (PE) ratio?

MDBIF's trailing twelve-month PE ratio is -0.01, based on current price and earnings per share data available on Stocks360.

What is MDBIF's market capitalization?

MDBIF's market capitalization is $8,191,199.00, placing it in the small-cap tier.

TrivarX Limited (MDBIF)

Stock analysis · OTC · Healthcare · Medical - Healthcare Information Services

$0.01

Market Cap

$8.19M

PE (TTM)

-0.01

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.84

Day Range

$0.01 – $0.01

52-wk Range

$0.00 – $0.03

Avg Volume

N/A

Volume

20.00K

TrivarX Limited (MDBIF) is a publicly traded company in the Healthcare sector. Latest price: $0.01. Market cap $8.19M. Trailing PE -0.01. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.02 2026-10-26 · $0.01 (-70.84%)

Earnings

Next Earnings

Feb 19, 2027

EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About TrivarX Limited

TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market. The firm, which was founded in 1987 and is headquartered in Mount Lawley, Australia, changed its name to TrivarX Limited in October 2023, having previously operated under the name Medibio Limited.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.01×
P/S (TTM)	0.00×
P/B	0.00×
P/FCF (TTM)	-17.00×
EV / EBITDA	-3.55×
EV / Sales	0.00×
Earnings Yield	-13926.64%
Free Cash Flow Yield	-5.88%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$6.91M
Net Income (TTM)	-$1.29B
Free Cash Flow (TTM)	-$2.66M
Net Debt	-$2.32M
Working Capital	$2.02M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-44.34%
Return on Invested Capital	-52.32%